Abstract: The instant disclosure relates to cosmetic compositions that include a non-hydrophobically modified anionic polymer; a cationic surfactant, including a cationizable surfactant; a fatty alcohol; and a cosmetically acceptable solvent; wherein the pH of the composition is below 5. Methods for using such cosmetic compositions are also provided.

Abstract: Compositions including a plurality of particles that may be prepared from a chitosan salt and methods for preparing the same. The plurality of particles may have an average diameter ranging from about 100 ?m to about 750 ?m, such as from about 150 ?m to about 500 ?m; a steepness value ranging from about 30 to about 90; and an average aspect ratio greater than 0.6. The plurality of particles may be substantially spherical in shape, for example. Methods of preparation include electrospraying a chitosan salt solution through a needle.

Abstract: A platform drug delivery system and a method of improving the delivery of low solubility pharmaceuticals utilizing crystal engineering and Theanine dissolution resulting in enhanced bioactivity, dissolution rate, and solid state stability.

Abstract: The present invention relates to a transdermal therapeutic system for cutaneous administration of fampridine. The system includes an active ingredient-impermeable backing layer, a pressure-sensitive adhesive reservoir layer and optionally a detachable protective layer. The pressure-sensitive adhesive reservoir layer is formed from fampridine and at least one matrix polymer containing no free carboxylic acid and/or carboxylate groups, with the content of fampridine in the matrix polymer being <5% by weight. On account of the low loading and also the lack of carboxylic acid and/or carboxylate groups in the reservoir layer, it is ensured that the systems administer the active ingredient substantially at higher administration rates than is known in the prior art, and compared to known systems a comparable thermodynamic activity of the active ingredient is achieved. The present invention further relates to a process for producing corresponding transdermal therapeutic systems.

Abstract: The present invention relates to compounds of Formula (I) or an agronomically acceptable salt of said compounds wherein Q, R1, R2, n and m are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.

Abstract: Disclosed herein is a herbicide and methods for the control of a grass or a broadleaf weed in a crop. The herbicide comprises an effective amount glufosinate, or a salt thereof, and an effective amount of a metabolic inhibitor.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(isonicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(isonicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: In some aspects, the present disclosure pertains to a polymer that comprises a plurality of polymer arms, wherein a first portion of the polymer arms comprise a reactive end group and wherein a second portion of the polymer arms comprise a branched end group that comprise a plurality of covalently attached diagnostic and/or therapeutic groups, which may be, for example, radiocontrast groups or radioactive groups. Other aspects pertain to a system that comprises (a) a first composition comprising such a polymer and (b) a second composition comprising a multifunctional compound that comprises reactive functional groups that are reactive with the reactive end group of the multi-arm polymer. Still other aspects pertain to a crosslinked reaction product of (a) such a polymer and (b) a multifunctional compound that comprises functional groups that are reactive with the reactive end group of the multi-arm polymer.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(isonicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: Disclosed are polymers, methods of making polymers, and compositions, focused on cross-linking heterocycles comprising a moiety of Formula I with thiols and thiolates.

Abstract: Provided are treprostinil derivatives with a reduced ability to form undesired impurities in a pharmaceutical formulation, such as a dry powder formulation, further containing a carboxyl group containing inactive ingredient, such as fumaryl diketopiperazine.

Abstract: The present invention relates to the use of a fructooligosaccharide (FOS) comprising from 2 to 10 monosaccharide units, as an elicitor of the mechanisms of absorption of mineral elements from the soil, and of the defense mechanisms against pathogens. It also relates to a fertilizing and biostimulating composition containing these fructooligosaccharides, and to the use thereof in a method for treating crop plants.

Abstract: Termite trailing and recruitment compositions, systems, devices, and methods for using a trail of a percentage 2 phenoxyethanol (2-PE) dissolved in water to form a trail to lead the subterranean termites to termite bait or monitoring stations located about a perimeter of a wood containing structure. The termite bait or monitoring stations can be located up to approximately 20 feet apart from one another, and the trail of a percentage 2 phenoxyethanol (2-PE) dissolved in water. The percentage 2 phenoxyethanol (2-PE) dissolved in water range from approximately 0.1% to approximately 2% depending on the different soil types and localized conditions. The types of soil can commonly include sand, sandy & silty soil, loam and clay soil.

Abstract: The present invention generally relates to the field of plant protection products and concerns a method for inducing acquired resistance in a plant to a plant pathogen, comprising obtaining or providing a composition comprising 1-hydroxypiperidine-2-carboxylic acid or a salt or derivative thereof, and contacting a plant with said composition, thereby inducing acquired resistance in the plant to the plant pathogen. Further, the present invention relates to the use of 1-hydroxypiperidine-2-carboxylic acid or a salt or derivative thereof for inducing acquired resistance in a plant to a plant pathogen. Also encompassed by the present invention are a plant seed coated with a composition comprising 1-hydroxypiperidine-2-carboxylic acid or a salt or derivative thereof, an irrigation system filled with irrigation water comprising 1-hydroxypiperidine-2-carboxylic acid or a salt or derivative thereof in a concentration of at least 0.

Abstract: The uses of the disclosed copper-cysteamine (Cu-Cy) complex for methods for treating Gram-positive and Gram-negative infections in subjects and for disinfecting a surface are disclosed. In addition, the disclosed Cy-Cy nanoparticles provide Fenton-like reactions in vivo, in vitro and ex vivo.

Abstract: The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q1, Q2, R1, R2, R3a, R3b, R4 and R5 have the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.

Abstract: An object of the present invention is to provide compounds represented by the formula (1) or salts thereof that are effective as agricultural and horticultural fungicides.

Abstract: A method for forming a biocompatible structure includes the steps of forming a layered structure having alternatively disposed first layers and second layers, where the first layers includes at least one polymer and first particles, and the second layers includes second particles; and treating the layered structure with a washing solvent to form the biocompatible structure, where the first particles are solvable in the washing solvent.

Abstract: Implant devices are coated with biologically active compounds, in particular with plant extracts from vinification residues. The implant devices are bone implants, and in particular dental implants. A method for functionalizing a surface of an implant device is includes the steps of a) optionally, treating the surface of the implant device with air, oxygen, argon, nitrogen plasma, and plasma capable of removing the surface layer of hydrocarbon contamination, b) treating the surface of the implant with an amine substrate, c) treating the surface of the implant resulting from step b), alternatively with a marcs extract, and drying the functionalized surface, or by co-adsorbing a marcs extract and hyaluronic acid, and drying the functionalized surface, or by adsorbing hyaluronic acid and post-adsorbing a marcs extract, and drying of the functionalized surface.